Skip to Main Content

Effective February 1, 2027: Pharmacy and Biopharmacy Policies

Date: 11/20/26

Ambetter from Superior HealthPlan, Ambetter Health (Solutions), and Superior HealthPlan (Medicaid and CHIP) has added, updated, or retired certain pharmacy and biopharmacy policies to ensure medical necessity review criteria is current and appropriate for members and the scope of services provided. As a result, the following policies are effective on February 1, 2027, at 12:00 AM.

Policy

Applicable Products

New Policy Overview or Updated Policy Revisions

Lirafugratinib (Lyrfigtu) (CP.PHAR.812)

Ambetter Health, Ambetter

Policy created.

Rusfertide (Mimrylo)
 (CP.PHAR.813)

Ambetter Health, Ambetter, and Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP

Policy created.

To review all policies, please visit Superior’s Clinical, Payment & Pharmacy Policies webpage.

Prior to updates, pharmacy and biopharmacy clinical policies are reviewed and approved by the Pharmacy and Therapeutics (P&T) Committee.

For questions or additional information, please contact the Centene Pharmacy Services (CPS) at 1-866-768-7147.